Add this result to my export selection buprenorphine and naloxone (Zubsolv) Source: Scottish Medicines Consortium - SMC (Remove filter) Indication: Napp Pharmaceuticals Ltd Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection rimonabant 20mg tablet (Acomplia) Source: Scottish Medicines Consortium - SMC (Remove filter) 12 February 2007 Indication: Obesity Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection padeliporfin (TOOKAD) Source: Scottish Medicines Consortium - SMC (Remove filter) 06 August 2018 Indication: Steba Biotech Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection olaratumab (Lartruvo) Source: Scottish Medicines Consortium - SMC (Remove filter) Indication: Eli Lilly and Company Ltd Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection elbasvir-grazoprevir (Zepatier) Source: Scottish Medicines Consortium - SMC (Remove filter) 16 January 2017 Indication: Treatment of chronic hepatitis C (CHC) in adults. (The efficacy of elbasvir-grazoprevir has not been demonstrated in genotypes 2, 3, 5 and 6. Elbasvir-grazoprevir is not recommended in... Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection Eflornithine 11.5% cream (Vaniqa®) Source: Scottish Medicines Consortium - SMC (Remove filter) 09 May 2005 Indication: Facial hirsutism in woman Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection Eflornithine 11.5% cream (Vaniqa®) Source: Scottish Medicines Consortium - SMC (Remove filter) 12 September 2005 Indication: Facial hirsutism in woman Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection eltrombopag (Revolade) Source: Scottish Medicines Consortium - SMC (Remove filter) 09 December 2013 Indication: In adult patients with chronic hepatitis C virus infection, for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or... Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection eltrombopag (Revolade) Source: Scottish Medicines Consortium - SMC (Remove filter) 09 August 2010 Indication: Adult chronic immune (idiopathic) thrombocytopenic purpura (ITP) splenectomised patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins). Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection elotuzumab (Empliciti) Source: Scottish Medicines Consortium - SMC (Remove filter) 08 August 2016 Indication: Treatment of multiple myeloma in combination with lenalidomide and dexamethasone in adult patients who have received at least one prior therapy. Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection eltrombopag (Revolade) Source: Scottish Medicines Consortium - SMC (Remove filter) 16 January 2017 Indication: Chronic immune (idiopathic) thrombocytopenic purpura (ITP) patients aged 1 year to 17 years who are refractory to other treatments (e.g. corticosteroids, immunoglobulins). Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection eltrombopag olamine (Revolade) Source: Scottish Medicines Consortium - SMC (Remove filter) 13 June 2016 Indication: treatment in adult patients with acquired severe aplastic anaemia (SAA) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for... Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate (Genvoya) Source: Scottish Medicines Consortium - SMC (Remove filter) 09 May 2016 Indication: treatment of adults and adolescents (aged 12 years and older with body weight at least 35kg) infected with human immunodeficiency virus-1 (HIV-1) without any known mutations associated... Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection empagliflozin (Jardiance) Source: Scottish Medicines Consortium - SMC (Remove filter) 13 October 2014 Indication: Treatment of type 2 diabetes to improve glycaemic control in adults as add-on combination therapy: in combination with other glucose–lowering medicinal products including insulin, when... Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection empagliflozin/metformin (Synjardy) Source: Scottish Medicines Consortium - SMC (Remove filter) 12 October 2015 Indication: in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control / in patients inadequately controlled on their maximally... Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection elvitegravir 150mg, cobicistat 150mg, emtricitabine 200mg, tenofovir disoproxil (as fumarate) 245mg film coated tablet (Stribild®) Source: Scottish Medicines Consortium - SMC (Remove filter) 12 August 2013 Indication: For treatment of human immunodeficiency virus-1 (HIV-1) infection in adults aged 18 years and over who are antiretroviral treatment-naïve or are infected with HIV-1 without known... Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection emtricitabine / tenofovir / rilpiverine (Eviplera) Source: Scottish Medicines Consortium - SMC (Remove filter) 13 February 2012 Indication: For the treatment of HIV-1 infection in adults Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection emtricitabine/tenofovir alafenamide (Descovy) Source: Scottish Medicines Consortium - SMC (Remove filter) 08 August 2016 Indication: In combination with other antiretroviral agents for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35kg) infected with human immunodeficiency... Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection Emtricitabine 200 mg hard capsules (Emtriva®) Source: Scottish Medicines Consortium - SMC (Remove filter) 13 February 2006 Indication: HIV-1 infected adults in combination with other antiretroviral agents Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection emtricitabine/tenofovir disoproxil 200mg/245mg film-coated tablets (Truvada) Source: Scottish Medicines Consortium - SMC (Remove filter) Indication: Treatment of HIV-1 infected adolescents aged 12 to <18 years with nucleoside reverse transcriptase inhibitor resistance or toxicities precluding the use of first line agents. Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection Enfuvirtide (Fuzeon®) Source: Scottish Medicines Consortium - SMC (Remove filter) 11 August 2003 Indication: HIV Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection fentanyl (Instanyl) Source: Scottish Medicines Consortium - SMC (Remove filter) 09 November 2009 Indication: Management of breakthrough pain in adults already receiving maintenance opioid therapy for chronic cancer pain. Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection febuxostat (Adenuric) Source: Scottish Medicines Consortium - SMC (Remove filter) 13 September 2010 Indication: Chronic hyperuricaemia Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection febuxostat (Adenuric) Source: Scottish Medicines Consortium - SMC (Remove filter) 13 June 2016 Indication: for the prevention and treatment of hyperuricaemia in adult patients undergoing chemotherapy for haematologic malignancies at intermediate to high risk of Tumour Lysis Syndrome (TLS). Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection ezetimibe/simvastatin (Inegy) Source: Scottish Medicines Consortium - SMC (Remove filter) 13 June 2005 Indication: Hypercholesterolaemia and Homozygous Familial Hypercholesterolaemia Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection fentanyl citrate (Breakyl) Source: Scottish Medicines Consortium - SMC (Remove filter) 13 January 2014 Indication: Treatment of breakthrough pain (BTP) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain. Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection fentanyl (Ionsys) Source: Scottish Medicines Consortium - SMC (Remove filter) 12 December 2016 Indication: Management of acute moderate to severe post-operative pain in adult patients Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection fentanyl (Instanyl) Source: Scottish Medicines Consortium - SMC (Remove filter) 16 January 2012 Indication: For the management of breakthrough pain in adults already receiving maintenance opioid therapy for chronic cancer pain. Breakthrough pain is a transitory exacerbation of pain that occurs... Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection fentanyl buccal tablets (Effentora) Source: Scottish Medicines Consortium - SMC (Remove filter) 09 February 2009 Indication: Breakthrough pain in adults with cancer Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection fentanyl pectin nasal spray (PecFent) Source: Scottish Medicines Consortium - SMC (Remove filter) 17 January 2011 Indication: Management of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection fenticonazole (Ginoxin) Source: Scottish Medicines Consortium - SMC (Remove filter) Indication: treatment of vulvovaginal candidiasis. Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection fentanyl sublingual (Abstral) Source: Scottish Medicines Consortium - SMC (Remove filter) 09 February 2009 Indication: Management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection ferric carboxymaltose (Ferinject) Source: Scottish Medicines Consortium - SMC (Remove filter) 13 June 2011 Indication: Treatment of iron deficiency when oral preparations are ineffective or cannot be used Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection fidaxomicin (Dificlir) Source: Scottish Medicines Consortium - SMC (Remove filter) 09 July 2012 Indication: Treatment of clostridim difficile infections (CDI) also known as C. Difficile-associated diarrhoea (CDAD) Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection ferric maltol (Feraccru) Source: Scottish Medicines Consortium - SMC (Remove filter) 12 December 2016 Indication: In adults for the treatment of iron deficiency anaemia (IDA) in patients with inflammatory bowel disease (IBD). Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection fesoterodine fumarate (Toviaz) Source: Scottish Medicines Consortium - SMC (Remove filter) 07 July 2008 Indication: Treatment of the symptoms of increased urinary frequency and/or urgency incontinence) that may occur in patients with overactive bladder (OAB) syndrome Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection ferumoxytol (Rienso) Source: Scottish Medicines Consortium - SMC (Remove filter) 11 February 2013 Indication: For the intravenous treatment of iron deficiency anaemia (IDA) in adult patients with chronic kidney disease (CKD). Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection fingolimod (Gilenya) Source: Scottish Medicines Consortium - SMC (Remove filter) 13 April 2015 Indication: As a single disease modifying therapy in highly active relapsing remitting multiple sclerosis (RRMS) for the following adult patient groups: Patients with high disease activity despite... Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection filgrastim (Nivestim) Source: Scottish Medicines Consortium - SMC (Remove filter) 07 February 2011 Indication: for the reduction in the duration of neutropenia and the incidence of febrile neutropenia (FN) in patients treated with established cytotoxic chemotherapy for malignancy (with the... Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection filgrastim (Zarzio) Source: Scottish Medicines Consortium - SMC (Remove filter) 13 June 2011 Indication: Neutropenia Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection filgrastim (Ratiograstim) Source: Scottish Medicines Consortium - SMC (Remove filter) 09 November 2009 Indication: Reduction in the duration of neutropenia and the incidence of febrile neutropenia Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection filgrastim (TevaGrastim) Source: Scottish Medicines Consortium - SMC (Remove filter) 09 August 2010 Indication: Reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic... Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection fludarabine, 10mg tablet and 50mg for injection or infusion (Fludara) Source: Scottish Medicines Consortium - SMC (Remove filter) 13 November 2006 Indication: B-cell chronic lymphocytic leukaemia Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection fingolimod (Gilenya) Source: Scottish Medicines Consortium - SMC (Remove filter) 10 September 2012 Indication: As single disease modifying therapy in highly active relapsing remitting multiple sclerosis (RRMS) for the following adult patient groups: Patients with high disease activity despite... Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection fingolimod (Gilenya) Source: Scottish Medicines Consortium - SMC (Remove filter) 13 October 2014 Indication: As a single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following adult patient groups: Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection fluocinolone acetonide (Iluvien) Source: Scottish Medicines Consortium - SMC (Remove filter) 10 February 2014 Indication: treatment of vision impairment associated with chronic diabetic macular oedema, considered insufficiently responsive to available therapies. Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection flecainide 200mg caps (Tambocor XL) Source: Scottish Medicines Consortium - SMC (Remove filter) 08 December 2008 Indication: AV nodal reciprocating tachycardia, arrhythmias associated with Wolff-Parkinson-White Syndrome and similar conditions with accessory pathways Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection fluorouracil + salicylic acid (Actikerall) Source: Scottish Medicines Consortium - SMC (Remove filter) 10 October 2011 Indication: For the topical treatment of hyperkeratotic actinic keratosis. Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection fluticasone furoate (Avamys) Source: Scottish Medicines Consortium - SMC (Remove filter) 14 April 2009 Indication: Allergic rhinitis in adults adolescents (12 years+) and children (6 to 11 years) Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)
Add this result to my export selection fluticasone furoate/vilanterol (Relvar Ellipta) Source: Scottish Medicines Consortium - SMC (Remove filter) 07 April 2014 Indication: Symptomatic treatment of adults with chronic obstructive pulmonary disease (COPD) with a forced expiratory volume in 1 second (FEV1) <70% predicted normal (post-bronchodilator) with an... Type: Prescribing and Technical Information (Add filter) Type: Guidance (Add filter)